Clinical trials operate through coordinated roles, structured responsibilities, and continuous oversight across study activities. Each action, from participant interaction to data handling and safety reporting, must align with an authorised individual and a defined scope of responsibility.

Research teams manage multiple staff members, evolving study requirements, and ongoing updates throughout the trial lifecycle. This creates a need for a clear system that maintains alignment between roles, responsibilities, approvals, and actual study execution.

Let us break down how responsibility is structured, assigned, and maintained across clinical trials, with a focus on operational clarity, regulatory alignment, and audit readiness.

Key Takeaways from AQ’s Guide to DOA

• Clear assignment of roles ensures structured execution across study activities
• Responsibility remains anchored at the investigator level with defined oversight
• Study tasks must align with staff qualifications, training, and role scope
• Delegation records must reflect real-time study activity and updates
• Timing of role assignment and approval directly impacts compliance
• Audit readiness depends on alignment between execution, documentation, and authorisation
• Common delegation gaps lead to traceability, qualification, and timing risks
• Digital systems enable continuous alignment between roles, tasks, and approvals
• Integrated platforms connect delegation with study execution, documentation, and quality processes

AQ’s DOA guide provides a complete view of how delegation operates across clinical trials and how structured systems ensure clarity, control, and compliance at every stage.

What is Delegation of Authority (DOA)?

Delegation of Authority (DOA) is a structured process in clinical research where the Principal Investigator (PI) assigns specific study-related tasks and responsibilities to qualified site personnel, while retaining overall accountability for the conduct of the trial.

It is documented through a Delegation of Authority log, which records:

• who is involved in the study
• what tasks are assigned to each individual
• when those responsibilities are active
• whether the individual is qualified and authorised

The DOA log functions as a control record that connects person → role → task → approval → execution within a clinical trial.

From a regulatory perspective, DOA demonstrates that:

• study activities are performed by appropriately trained and qualified individuals
• responsibilities are clearly assigned and authorised by the PI
• investigator oversight is maintained throughout the study

It is important to understand that delegation does not transfer responsibility. In fact, the PI remains accountable for all delegated activities, which makes accurate and timely documentation of DOA essential for compliance, participant safety, and data integrity.

In practice, DOA operates as a continuous process. It begins at study setup, evolves with staff and role changes, and remains active throughout the trial lifecycle to ensure that every task is performed by an authorised individual at the correct time.

Also Read: What is an eTMF in Clinical Trial Research?

Core Principle of DOA

Delegation of Authority establishes a controlled link between people, roles, and study activities.

Each task is assigned to a specific individual based on defined role, verified qualification, and recorded approval. This structure ensures that study execution follows a clear chain of authority from assignment to action.

The Principal Investigator anchors this structure by defining roles, approving responsibilities, and maintaining continuous oversight across all delegated functions.

A valid DOA framework maintains:

• clear ownership of every study task
• alignment between role and responsibility
• documented authorisation before activity begins
• continuous visibility of who performs each action

This principle ensures that every activity within a clinical trial remains structured, traceable, and aligned with defined authority at all times.

Also Read: What is ePSF in Clinical Trial Data Management?

Traditional vs Digital DOA Systems

 

Delegation of Authority shifts from static documentation to system-driven control when managed digitally, where role assignment, approvals, and study activities remain continuously aligned instead of being maintained as separate records.

Aspect	Traditional DOA	Digital DOA
Structure	Paper logs or spreadsheets	Centralised system
Updates	Manual and periodic	Real-time and continuous
Role visibility	Limited across teams	Unified across all users
Task alignment	Separate from study activity	Directly linked to execution
Approvals	Delayed or batch-based	Instant and controlled
Traceability	Partial and fragmented	Complete audit trail
Compliance control	Retrospective validation	Pre-execution enforcement
Audit readiness	Requires preparation	Always inspection-ready

 

Also Read: What is CAPA Management Software in Clinical Research?

Why is Digital DOA Required in Clinical Trials?

• Centralised control over role assignment across studies and sites
• Real-time alignment between delegation and study activity
• Direct linkage between authorised personnel and executed tasks
• Continuous visibility of roles, responsibilities, and approvals
• Structured enforcement of delegation before task execution
• Integrated validation of training, qualifications, and permissions
• Elimination of duplicate records across systems and documents
• Immediate reflection of role changes and study updates
• Complete, time-stamped audit trails for all delegation actions
• Consistent responsibility tracking across CTMS, eTMF, eISF, and QMS
• Reduced administrative effort through automated workflows
• Improved coordination across investigators, coordinators, and site teams
• Accurate tracking of start and end dates for role validity
• Faster audit response with organised, exportable records
• Continuous inspection readiness with system-driven compliance

Also Read: What is CTMS

What Tasks are Delegated for Clinical Trial Data Management?

 

Task	Assigned To	Why This Delegation
Source data creation and documentation	Study Coordinator / Site Staff	Direct interaction with participants and access to clinical records ensures accurate primary data capture
CRF data entry in EDC	Study Coordinator / Data Entry Staff	Operational role responsible for timely transcription of source data into structured systems
Source Data Verification (SDV)	Clinical Research Associate (CRA)	Independent review ensures data accuracy and alignment between source and EDC
Data query review and resolution	Study Coordinator / Investigator (as required)	Site ownership of data enables clarification based on source records and clinical context
Adverse Event (AE/SAE) data recording	Study Coordinator with PI oversight	Clinical relevance requires site-level documentation with medical oversight
Medical coding (MedDRA, WHO Drug)	Data Management Team	Standardisation requires specialised coding knowledge and consistency across datasets
Data validation and consistency checks	Data Management Team	Centralised review ensures protocol alignment and dataset integrity
Data reconciliation (lab, imaging, IP)	Data Management Team with Site Support	Cross-system consistency requires coordination between central and site-level data sources
Protocol deviation documentation (data-related)	Study Coordinator / Quality Team	Site-level visibility ensures accurate capture of deviations linked to study conduct
Data cleaning and discrepancy management	Data Management Team	Central responsibility for identifying and resolving inconsistencies across datasets
Database status tracking and completeness review	Data Management Team	Oversight of dataset readiness for analysis and reporting
Interim data review preparation	Data Management Team / Biostatistics	Structured dataset preparation required for analysis cycles
Database lock preparation and support	Data Management Team with PI confirmation	Final validation ensures data completeness before locking
Audit trail maintenance and data change tracking	System-driven (EDC/CTMS) with oversight by Data Management	Automated tracking ensures traceability of all data modifications
Data extraction and reporting	Data Management / Biostatistics	Controlled data output required for analysis, monitoring, and regulatory use
Coordination across data stakeholders	Study Coordinator / Data Manager	Ensures alignment between site operations, data teams, and study timelines

Who is Involved in Delegation of Authority?

Delegation of Authority includes all individuals who contribute to study execution, data handling, oversight, and compliance. Each role is assigned specific responsibilities based on qualifications, training, and involvement in the clinical trial. This ensures that every study activity is performed by an authorised individual with clear ownership and defined scope.

• Principal Investigator (PI)
  Defines roles, assigns responsibilities, approves delegation, and maintains overall study oversight
• Sub-Investigator (Sub-I)
  Performs clinical assessments and supports medical decision-making under PI supervision
• Study Coordinator (CRC)
  Manages daily study operations, participant coordination, documentation, and workflow execution
• Study Nurse / Site Staff
  Conducts study visits, performs procedures, and collects participant data
• Pharmacist / Investigational Product (IP) Manager
  Manages drug storage, dispensing, accountability, and pharmacy documentation
• Data Entry and Regulatory Staff
  Handles CRF entry, maintains regulatory records, and supports documentation workflows
• Clinical Research Associate (CRA)
  Monitors study conduct, verifies data accuracy, and reviews delegation alignment during site visits
• Data Management Team
  Performs data validation, coding, reconciliation, and dataset preparation for analysis
• Quality and Compliance Team
  Oversees deviations, audits, CAPA processes, and ensures adherence to regulatory standards

Also Read: What is QMS (Quality Management System) in Clinical Research?

Delegation of Authority Log Structure

The Delegation of Authority (DOA) log defines how responsibilities are assigned, approved, and tracked across study personnel. Each field in the log captures a specific element required to link a task with an authorised individual and a defined timeframe.

Let’s consider an example.

A clinical trial site initiates a Phase II study. The Principal Investigator assigns Sarah Khan as a Study Coordinator responsible for participant coordination, informed consent, and data entry.

The DOA log captures this assignment in a structured format:

• Staff Name and Role
  Sarah Khan is listed as Study Coordinator. This identifies who performs the assigned tasks.
• Delegated Tasks and Responsibilities
  Tasks include informed consent process, CRF data entry, and visit coordination. This defines what she is authorised to perform.
• Signature and Initials
  Sarah provides her signature and initials (SK). This allows verification across source documents and study records.
• Start Date of Delegation
  The start date is recorded as 01 March 2026. This defines when task execution becomes valid.
• Principal Investigator Approval
  The PI approves the delegation on 28 February 2026. This confirms authorisation before task execution begins.
• Training and Qualification Reference
  Sarah completes GCP training and protocol training. This supports that assigned tasks align with her qualifications.
• End Date of Delegation
  The end date is recorded as 30 September 2026. This defines the active duration of her responsibilities.
• Update and Change History
  A later update adds AE reporting responsibility on 15 April 2026. This reflects changes in role scope during the study.

When and How DOA Must Be Updated During a Study?

Delegation updates follow actual study activity. Each change in staff, role, or protocol creates a direct update requirement in the DOA log. The update reflects who performs which task, from what date, and under whose approval.

Example Scenario: Mid-Study Role Change and Audit Trace

A Phase III multi-site oncology study runs with active recruitment. At Site A, the study coordinator handles consent, CRF entry, and visit coordination.

Situation 1: New Staff Onboarding

A new coordinator, John, joins on 10 June 2026 to support increasing patient load.

What happens operationally:

• Ali completes GCP and protocol training on 11 June
• PI reviews qualifications on 12 June
• DOA entry is created with assigned tasks: CRF entry and visit scheduling
• PI approval is recorded on 12 June
• Start date is set as 12 June 2026

Impact: John gains system access and begins tasks from 12 June. Every data entry action now traces back to his authorised role and start date.

Situation 2: Role Expansion Based on Study Needs

Patient volume increases. John starts supporting AE reporting from 25 June 2026.

What changes in DOA:

• New responsibility added under his name
• Training for AE reporting completed on 24 June
• PI approves expanded role on 25 June
• Update recorded with effective date

Impact: AE entries after 25 June align with his updated delegation. Earlier entries remain tied to previous scope.

Situation 3: Staff Exit and Responsibility Cut-Off

The original coordinator, Sarah Khan, exits the study on 05 July 2026.

What happens in DOA:

• End date recorded as 05 July 2026
• Her responsibilities remain valid only until that date
• System access aligns with end date

Impact: Any activity after 05 July cannot be attributed to Sarah. Audit trace remains clean and time-bound.

Situation 4: Audit Review (Real Validation Point)

An auditor reviews:

• AE reported on 28 June
• CRF entry on 03 July

DOA trace shows:

• Ali authorised for AE reporting from 25 June
• Sarah active until 05 July
• Each action aligns with valid delegation period

Outcome: Clear linkage between:

• task performed
• authorised individual
• approval date
• training status 

Common Delegation of Authority Errors in Clinical Research

• Staff performing study tasks before delegation is recorded and approved
• Study personnel involved in trial activities missing from the DOA log
• Delegated responsibilities not aligned with staff qualifications or training
• Principal Investigator approval recorded after task execution
• Missing or incomplete training documentation linked to delegated tasks
• Inconsistent signatures and initials across study records and DOA log
• Delegation entries without clear start dates or incorrect effective dates
• Missing end dates for staff who exit the study or change roles
• Responsibilities assigned broadly without clear task-level definition
• Failure to update DOA after protocol amendments affecting responsibilities
• Duplicate or conflicting DOA records across paper logs and systems
• Delegation not aligned with actual study activity or system access
• Delayed updates following staff onboarding or role changes
• Lack of version control or history tracking for delegation updates
• Incomplete linkage between DOA, training records, and study documentation
• Absence of PI oversight evidence across delegation changes
• Over-assignment of tasks without clear ownership or accountability
• Delegation records maintained retrospectively instead of reflecting real-time activity 

How DOA Failures Lead to Audit Findings and Compliance Risks?

DOA failures appear when study activity, delegation records, and approvals fall out of alignment. Auditors review this alignment through three core checks: who performed the task, whether they were authorised, and whether timing matched delegation. Any mismatch converts into a finding.

1. Authorisation Misalignment

 

Scenario	What Happens	Audit Finding	Compliance Risk
Task executed before PI approval	Consent taken on 12 May, approval dated 15 May	Activity performed without prior authorisation	Questioned validity of consent and participant eligibility
Staff not listed in DOA	Nurse performs visits without DOA entry	Unauthorised personnel involved in study	Loss of traceability and weak oversight

 

2. Qualification and Training Misalignment

 

Scenario	What Happens	Audit Finding	Compliance Risk
Task assigned beyond qualification	Data staff performs eligibility assessment	Role-task mismatch	Incorrect clinical evaluation
Missing training evidence	AE reporting assigned without protocol training	Task performed without competency validation	Inaccurate safety reporting

 

3. Timing and Lifecycle Misalignment

 

Scenario	What Happens	Audit Finding	Compliance Risk
Missing end date after staff exit	Staff remains active in DOA after leaving	Delegation period unclear	Responsibility tracking breakdown
Delayed DOA updates	Role changes applied later in records	DOA does not reflect actual activity	Misalignment between execution and documentation

 

4. Traceability Gaps

 

Scenario	What Happens	Audit Finding	Compliance Risk
Inconsistent signatures	Source documents and DOA initials do not match	Identity verification gap	Data ownership concerns
Fragmented delegation records	DOA spread across logs and systems	Incomplete audit trail	Difficulty verifying responsibility

 

Also Read: DMS vs eQMS in Clinical Trial Data Management

AQ Digital DOA: System-Controlled Delegation, Role-Based Authority, and Audit-Ready Responsibility 

AQ Digital DOA establishes a controlled environment where role assignment, delegation, and study execution remain continuously aligned across clinical trial operations. It connects delegation records with real study activity, so each task, document action, and workflow reflects the authorised individual responsible at that point in time.

Traditional delegation approaches rely on separate logs and manual updates. AQ brings delegation into a single system where roles, responsibilities, approvals, and timelines operate together with full traceability.

• Centralised role assignment and delegation control
  All study personnel, roles, and responsibilities remain defined within one system, creating a consistent source of truth
• Direct linkage between tasks and authorised personnel
  Study activities across CTMS, eTMF, eISF, ePSF, and QMS align with assigned roles, ensuring each action reflects approved delegation
• Pre-execution authorisation and role validation
  Task access aligns with approved delegation, role permissions, and training status before activity begins
• Real-time updates across study operations
  Role changes, staff onboarding, and responsibility updates reflect immediately across all connected modules
• Time-bound delegation with full lifecycle tracking
  Start and end dates define active responsibility periods, maintaining accurate alignment with study timelines
• Complete audit trails and delegation history
  Every assignment, approval, and update is recorded with user identity and timestamp, supporting inspection-ready traceability

AQ Digital DOA transforms delegation into a system-driven control layer where responsibility remains clearly defined, continuously validated, and directly connected to execution across the entire study lifecycle.

Request a live demo to see how AQ Digital DOA manages delegation, role assignment, and responsibility with full traceability across your clinical research operations.